[
  {
    "ts": null,
    "headline": "IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day",
    "summary": "IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=4fa13b0a9a38310f92ad85802e6deb3e3ba2a1ca1ae2ea0c8ca3fedd0872421c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750179120,
      "headline": "IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day",
      "id": 135362732,
      "image": "",
      "related": "IDXX",
      "source": "MarketWatch",
      "summary": "IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=4fa13b0a9a38310f92ad85802e6deb3e3ba2a1ca1ae2ea0c8ca3fedd0872421c"
    }
  },
  {
    "ts": null,
    "headline": "IDEXX Laboratories (IDXX) Price Target Hiked to $580 at Leerink Partners",
    "summary": "IDEXX Laboratories Inc. (NASDAQ:IDXX) is among the 12 best healthcare stocks. On June 11, Leerink Partners analyst Daniel Clark reiterated an Outperform rating on the stock. However, the analyst increased his stock price target to $580 from $515. According to the analyst IDEXX Laboratories has evolved to become the largest player in the veterinarian space. […]",
    "url": "https://finnhub.io/api/news?id=63445e0e6d4d35865f81a5d00d914d072a0622b011d54cde5bf22c5441ff9a29",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750141466,
      "headline": "IDEXX Laboratories (IDXX) Price Target Hiked to $580 at Leerink Partners",
      "id": 135318256,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "IDEXX Laboratories Inc. (NASDAQ:IDXX) is among the 12 best healthcare stocks. On June 11, Leerink Partners analyst Daniel Clark reiterated an Outperform rating on the stock. However, the analyst increased his stock price target to $580 from $515. According to the analyst IDEXX Laboratories has evolved to become the largest player in the veterinarian space. […]",
      "url": "https://finnhub.io/api/news?id=63445e0e6d4d35865f81a5d00d914d072a0622b011d54cde5bf22c5441ff9a29"
    }
  }
]